PROCEPT BioRobotics (PRCT) Competitors $92.70 -0.87 (-0.93%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PRCT vs. ATRI, TFX, NNOX, INGN, BNGO, SOLV, SNN, PEN, GKOS, and BLCOShould you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Atrion (ATRI), Teleflex (TFX), Nano-X Imaging (NNOX), Inogen (INGN), Bionano Genomics (BNGO), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), and Bausch + Lomb (BLCO). PROCEPT BioRobotics vs. Atrion Teleflex Nano-X Imaging Inogen Bionano Genomics Solventum Smith & Nephew Penumbra Glaukos Bausch + Lomb PROCEPT BioRobotics (NASDAQ:PRCT) and Atrion (NASDAQ:ATRI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment. Which has preferable earnings & valuation, PRCT or ATRI? Atrion has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$136.19M35.52-$105.90M-$1.95-47.54Atrion$181.60M4.46$19.41M$10.6443.23 Does the MarketBeat Community favor PRCT or ATRI? Atrion received 93 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. However, 66.67% of users gave PROCEPT BioRobotics an outperform vote while only 50.39% of users gave Atrion an outperform vote. CompanyUnderperformOutperformPROCEPT BioRoboticsOutperform Votes3666.67% Underperform Votes1833.33% AtrionOutperform Votes12950.39% Underperform Votes12749.61% Which has more risk and volatility, PRCT or ATRI? PROCEPT BioRobotics has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Atrion has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Do institutionals & insiders hold more shares of PRCT or ATRI? 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 66.2% of Atrion shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 22.8% of Atrion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media refer more to PRCT or ATRI? In the previous week, PROCEPT BioRobotics had 13 more articles in the media than Atrion. MarketBeat recorded 13 mentions for PROCEPT BioRobotics and 0 mentions for Atrion. PROCEPT BioRobotics' average media sentiment score of 0.78 beat Atrion's score of 0.00 indicating that PROCEPT BioRobotics is being referred to more favorably in the media. Company Overall Sentiment PROCEPT BioRobotics Positive Atrion Neutral Do analysts prefer PRCT or ATRI? PROCEPT BioRobotics presently has a consensus target price of $89.50, suggesting a potential downside of 3.45%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, research analysts plainly believe PROCEPT BioRobotics is more favorable than Atrion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Atrion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is PRCT or ATRI more profitable? Atrion has a net margin of 10.60% compared to PROCEPT BioRobotics' net margin of -50.07%. Atrion's return on equity of 7.75% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-50.07% -38.57% -26.06% Atrion 10.60%7.75%7.12% SummaryPROCEPT BioRobotics and Atrion tied by winning 9 of the 18 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRCT vs. The Competition Export to ExcelMetricPROCEPT BioRoboticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.88B$4.47B$5.06B$8.89BDividend YieldN/A36.79%4.97%4.06%P/E Ratio-47.5412.8689.0213.30Price / Sales35.5245.351,207.2881.01Price / CashN/A52.2339.1736.03Price / Book20.065.676.085.74Net Income-$105.90M$13.76M$119.07M$225.93M7 Day Performance7.90%-1.08%-1.84%-1.32%1 Month Performance35.92%0.58%-3.65%0.60%1 Year Performance174.91%50.91%31.62%26.23% PROCEPT BioRobotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRCTPROCEPT BioRobotics1.5836 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.88B$136.19M-47.54626ATRIAtrionN/A$459.92flatN/AN/A$809.46M$181.60M43.23720TFXTeleflex4.8737 of 5 stars$187.47-2.9%$259.25+38.3%-12.7%$8.97B$2.97B37.2714,500Analyst DowngradeNNOXNano-X Imaging1.7317 of 5 stars$5.89+3.5%$14.00+137.7%-10.5%$328.76M$9.90M0.00190INGNInogen3.0445 of 5 stars$9.46-0.3%$7.00-26.0%+63.4%$226.04M$315.66M-4.20834BNGOBionano Genomics1.3717 of 5 stars$0.21-8.7%$1.50+616.3%-85.7%$21.36M$36.12M-0.09300Gap UpHigh Trading VolumeSOLVSolventum1.804 of 5 stars$68.39+2.0%$68.00-0.6%N/A$11.58BN/A0.0022,000SNNSmith & Nephew2.1198 of 5 stars$25.22-1.2%N/A-1.4%$11.15B$5.55B0.0018,452PENPenumbra4.3167 of 5 stars$239.20+0.9%$227.92-4.7%+1.6%$9.10B$1.06B278.144,200Analyst ForecastInsider TradeGKOSGlaukos3.8428 of 5 stars$141.44-1.9%$134.55-4.9%+121.3%$7.95B$314.71M0.00780Positive NewsBLCOBausch + Lomb2.7887 of 5 stars$19.39-0.8%$20.91+7.8%+23.2%$6.83B$4.68B-18.4713,300 Related Companies and Tools Related Companies ATRI Competitors TFX Competitors NNOX Competitors INGN Competitors BNGO Competitors SOLV Competitors SNN Competitors PEN Competitors GKOS Competitors BLCO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRCT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRCT Stock Alerts